Alphabet (GOOGL.US) shares are extending their decline today, fighting to preserve the broader uptrend while testing the 200-day exponential moving average (EMA200) on the daily chart. Alphabet remains one of the three largest companies in the world and has delivered several record-breaking quarters in terms of both earnings growth and sales momentum.
-
Sentiment around the company has weakened noticeably in recent months, while investors have increasingly moved to take profits. As a result, the stock is now down around 20% from its all-time highs.
-
Since February 2025, Alphabet shares have fallen below the EMA200 four times, with only one of those moves developing into a substantially deeper decline, following the trade-war announcements made by Donald Trump in April 2025.
-
The shares are currently trading at around 10 times sales, roughly 17 times earnings, and about 21 times estimated earnings over the next 12 months, taking into account that Alphabet booked approximately $100 billion in extraordinary gains related to its stake in Anthropic.
Alphabet (GOOGL.US) chart
Investors are trying to keep the stock above $330 per share today, which could prove crucial for short-term momentum. A close below the 200-day exponential moving average could signal that the current weakness is not yet over, while a successful defense of the $330 area followed by a rebound toward $345 could potentially open the door to a renewed bullish move. In the longer term, the key resistance level remains around $400 per share, corresponding to the all-time highs reached in June.
Source: xStation5
US Open: Wall Street sentiments mixed as oil jumps above $100 ๐ฝ Casey General shares tumble 18%
Market Wrap: A sunk tanker drags european stocks lower
The US is pouring hundreds of millions more into quantum computing. This is only the beginning
US Open: NFP Has Shifted Fed Expectations, and Wall Street Now Awaits Inflation
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.